Smithsonian Institution

Search Results

Collections Search Center
1 documents - page 1 of 1

Sterling Drug, Inc. Records, 1867-1995

view Sterling Drug, Inc. Records, 1867-1995 digital asset number 1
Creator:
Sterling Drug, Inc
Creator:
Winthrop Chemical Company
Bayer Company
Donor:
History Factory Chantilly, Virginia
Subject:
Eastman Kodak Company
Physical description:
150 cu. ft. : 267 boxes
Type:
Financial records
Collection descriptions
Photographs
Newsletters
Clippings
Press releases
Business records
Manuals
Price lists
Catalogs
Brochures
Advertisements
Date:
1867
1867-1995
20th century
Notes:
Sterling Drug was founded in 1901 by William E. Weiss and Albert H. Diebold of Wheeling, West Viginia, to manufacture and sell a pain-relieving preparation called "Neuralgine". The company's original name was Neuralgyline. Within a few years, Weiss and Diebold realized that expansion required more product lines and that these would be best obtained by acquisition. This policy continued throughout the life of the organization. At least 130 companies were acquired between 1902 and 1986. Weiss and Diebold changed the name of the company in 1917 to Sterling Drug, Inc. Sterling Drug benefited from World War I. Because supplies of drugs from Germany were cut off by the Allied blockade, they set up the Winthrop Company to manufacture the active ingredients. After the war, Sterling acquired the American Bayer Company. They established a separate subsidiary, the Bayer Company, to market Bayer Aspirin. During the 1930s, Winthrop made Sterling a leader in the pharmaceutical field with such renowned products as Luminal, the original phenobarbitol; Salvarsan and Neo-Salvarsan, the first effective drugs in the treatment of syphillis; Prontosil, the first of the sulfa drugs; and Atabrine, the synthetic antimalarial that replaced quinine during World War II. The company expanded overseas in 1938, and eventually operated about seventy plants in about forty countries. Sterling was especially profitable in Latin America. In 1988, in order to avoid a hostile takeover by Hofmann-LaRoche, Sterling became a division of Eastman Kodak and remained one until 1994 when Kodak decided to dispose of its health-related businesses.
Summary:
The collection contains domestic and foreign advertising for both pharmaceutical and consumer health care products; sales and marketing materials for pharmaceuticals aimed at physicians, such as brochures, package inserts, reports, catalogs, price lists, manuals; the company's business and administrative papers, including annual reports, news releases, clippings, newsletters and publications, financial and corporate files, histories, memorabilia, and photographs.
Cite as:
Sterling Drug, Inc. Records, 1867-1995, Archives Center, National Museum of American History
Topic:
Antibiotics
Analgesics
Barbiturates
Anesthesia
Advertising
Medicine
Pharmaceutical industry
Local number:
2001.3045 (NMAH Acc.)
Data Source:
Archives Center - NMAH

Modify Your Search






or


Narrow By
  • Advertisements
  • Archival materials
  • Brochures
  • Business records
  • Catalogs
  • Clippings
  • Collection descriptions
  • Financial records
  • Manuals (instructional materials)
  • Newsletters
  • Advertisements
  • Archival materials
  • Brochures
  • Business records
  • Catalogs
  • Clippings
  • Collection descriptions
  • Financial records
  • Manuals (instructional materials)
  • Newsletters
  • Advertising
  • Barbiturates
  • Medicine
  • Pharmaceutical industry
  • Advertising
  • Barbiturates
  • Medicine
  • Pharmaceutical industry
  • Bayer Company
  • Eastman Kodak Company
  • History Factory
  • Sterling Drug, Inc
  • Winthrop Chemical Company
  • Bayer Company
  • Eastman Kodak Company
  • History Factory
  • Sterling Drug, Inc
  • Winthrop Chemical Company
Filter results to a specific time period.
  • 1860s
  • 1870s
  • 1880s
  • 1890s
  • 1900s
  • 1910s
  • 1920s
  • 1930s
  • 1940s
  • 1950s
  • Archives Center - NMAH